
France and US-based biopharma firm Cerenis Therapeutics has confirmed the appointment of Dr Richard Pasternak as its chairman of the …
The HDL drug specialist Cerenis Therapeutics has appointed Dr John Paolini as its new chief medical officer. Dr Paolini will …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

